New protein discovered by Hebrew University researchers
Jerusalem, January 6, 2005 Researchers at the Hebrew University of Jerusalem have succeeded in discovering and isolating a new protein from the poplar tree with special structural and qualitative characteristics that could have consequences for development of future nanocapsules for drug delivery to cancer cells....... ......In addition to being obtained from plant tissue, the protein can now...Hebrew University researcher finds 'sweet' way to help prevent heart disease
People who eat the Israeli-developed fruit known in Hebrew as pomelit (a cross between a grapefruit and a pomelo) or drink its juice regularly will be able to lower their blood cholesterol and increase their blood antioxidant activity, thus improving their chances of preventing blocked heart arteries and heart attacks, says a researcher at the Hebrew University of Jerusalem....... These findings...Cancer cell detection technology wins Kaye Award for Hebrew University researchers
A unique technology for optoelectronic detection of the presence of cancer cells has been developed at the Hebrew University of Jerusalem by a team of researchers headed by Itamar Willner, Enrique Berman Professor of Solar Energy at the Institute of Chemistry. ...... The technology detects the presence of telomerase, an active enzyme appearing in cancer cells that is considered a general marker...Novel 'delivery' method for nutrients wins Kaye Innovation Award for Hebrew university students
Increasingly, the public wants to "eat healthy," consuming foods that are high in the nutrients that are considered beneficial. The problem is that many of these food components are ultimately ineffective. ... ...This is so because most bioactive phytochemicals (chemical components derived from plants) are not soluble in water, and therefore their absorption via the digestive system i...Hebrew University one of 25 institutions involved in new European Vascular Genomics Network
The Hebrew University of Jerusalem is one of only 25 institutions represented in the European Vascular Genomics Network (EVGN), whose operational launch was announced this week by Inserm, the French National Institute of Health and Medical Research. EVGN is the first European Union-funded network in the field of cardiovascular diseases. ... ...The project is intended to integrate post-genomic res...New dressing for wounds developed at Hebrew University
A novel wound dressing made of genetically engineered human collagen that will enable faster and improved healing of injuries has been developed by researchers at the Hebrew University Faculty of Dental Medicine. ......Collagen is the most abundant protein in the animal kingdom, including humans. It is the major constituent of connective tissues tendons, skin, bones, cartilage, blood vessel wal...Antiepileptic drug developed at Hebrew University to undergo phase three clinical trials
The new antiepileptic drug valrocemide, developed at the Hebrew University of Jerusalem by Meir Bialer, the David Eisenberg Professor of Pharmacy, will undergo phase three clinical trials in the U.S. under a new agreement between Teva Pharmaceutical Industries of Israel and Acorda Therapeutics of the U.S. ... ...Teva acquired the rights to the drug from the Hebrew University's Yissum Research De...New biological sensors for detecting blood glucose developed by Hebrew University, U.S. Scientists
Jerusalem, March 26, 2003 Research conducted by scientists at the Hebrew University of Jerusalem and the U.S. Department of Energy's Brookhaven National Laboratory has paved the way for development of highly efficient sensors for measuring blood glucose in diabetic patients. The research, based on the use of nanotechnology, is described in the current issue of magazine. ... ...The Hebrew Uni...Hebrew University student developing drug to treat epilepsy, migraines, chronic pain
Jerusalem, June 6 Nina Isoherranen, a Ph.D. candidate at the Hebrew University School of Pharmacy, was awarded a Kaye Innovation Award this week for developing a new medication to treat epilepsy, migraine headaches, and chronic pain that does not cause birth defects in animal models, unlike other medicines currently used to treat epilepsy....... Ms. Isoherranen explained that 1% of the populatio...